Literature DB >> 16919768

Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project.

J W W Coebergh1, A M J Reedijk, E de Vries, C Martos, Z Jakab, E Steliarova-Foucher, W A Kamps.   

Abstract

Leukaemias constitute approximately one-third of cancers in children (age 0-14 years) and 10% in adolescents (age 15-19 years). Geographical patterns (1988-1997) and time trends (1978-1997) of incidence and survival from leukaemias in children (n=29,239) and adolescents (n=1929) were derived from the ACCIS database, including data from 62 cancer registries in 19 countries across Europe. The overall incidence rate of leukaemia in children was 44 per million person-years during 1988-1997. Lymphoid leukaemia (LL) accounted for 81%, acute non-lymphocytic leukaemia (ANLL) for 15%, chronic myeloid leukaemia (CML) for 1.5% and unspecified leukaemia for 1.3% of cases. Adjusted for sex and age, incidence of childhood LL was significantly lower in the East and higher in the North than in the British Isles. The overall incidence among adolescents was 22.6 per million person-years. The incidence of LL was rising in children (0.6% per year) and adolescents (1.9% per year). During 1988-1997 5-year survival of children with leukaemias was 73% (95% CI 72-74) and approximately 44% for infants and adolescents. Similar differences in survival between children and adolescents were observed for LL, much less so for ANLL. Survival differed between regions; prognosis was better in the North and West than the East. Remarkable improvements in survival occurred in most of the subgroups of patients defined by diagnostic subgroup, age, sex and geographic categories during the period 1978-1997. For children with ANLL most improvements in survival were observed in the 1990s.

Entities:  

Mesh:

Year:  2006        PMID: 16919768     DOI: 10.1016/j.ejca.2006.06.005

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  20 in total

Review 1.  Explanations for worsening cancer survival.

Authors:  Esther de Vries; Henrike E Karim-Kos; Maryska L G Janssen-Heijnen; Isabelle Soerjomataram; Lambertus A Kiemeney; Jan Willem W Coebergh
Journal:  Nat Rev Clin Oncol       Date:  2010-01       Impact factor: 66.675

Review 2.  Cancer of childhood in sub-Saharan Africa.

Authors:  Cristina Stefan; Freddie Bray; Jacques Ferlay; Biying Liu; D Maxwell Parkin
Journal:  Ecancermedicalscience       Date:  2017-07-28

3.  An epidemiological investigation of leukemia incidence between 2003 and 2007 in Nanjing, China.

Authors:  Bao-An Chen; Zhi-Hu Huang; Xiao-Ping Zhang; Jian Ou-Yang; Jian-Yong Li; Yong-Ping Zhai; Xue-Mei Sun; Yan-Li Xu; Qin Lu; Jian-Min Wang; Dong Li; Hui Liao; Zhi-Xiang Shen; Yan-Yan Wang; Xiao-Jing Yu; Hui Ye; Li-Ying Zhuang
Journal:  J Hematol Oncol       Date:  2010-06-02       Impact factor: 17.388

4.  Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007.

Authors:  R Marcos-Gragera; J Galceran; C Martos; A L de Munain; M Vicente-Raneda; C Navarro; J R Quirós-Garcia; M-J Sánchez; E Ardanaz; M Ramos; A Mateos; D Salmerón; S Felipe; R Peris-Bonet
Journal:  Clin Transl Oncol       Date:  2016-07-22       Impact factor: 3.405

5.  Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology.

Authors:  Keizo Horibe; Akiko M Saito; Tetsuya Takimoto; Masahiro Tsuchida; Atsushi Manabe; Midori Shima; Akira Ohara; Shuki Mizutani
Journal:  Int J Hematol       Date:  2013-05-24       Impact factor: 2.490

6.  Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia.

Authors:  Koichi Oshima; Hossein Khiabanian; Ana C da Silva-Almeida; Gannie Tzoneva; Francesco Abate; Alberto Ambesi-Impiombato; Marta Sanchez-Martin; Zachary Carpenter; Alex Penson; Arianne Perez-Garcia; Cornelia Eckert; Concepción Nicolas; Milagros Balbin; Maria Luisa Sulis; Motohiro Kato; Katsuyoshi Koh; Maddalena Paganin; Giuseppe Basso; Julie M Gastier-Foster; Meenakshi Devidas; Mignon L Loh; Renate Kirschner-Schwabe; Teresa Palomero; Raul Rabadan; Adolfo A Ferrando
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-21       Impact factor: 11.205

7.  Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002.

Authors:  Gemma Gatta; Silvia Rossi; Roberto Foschi; Annalisa Trama; Rafael Marcos-Gragera; Guido Pastore; Rafael Peris-Bonet; Charles Stiller; Riccardo Capocaccia
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

8.  Hematological malignancies diagnosed by bone marrow examination in a tertiary hospital at Uttarakhand, India.

Authors:  Anuradha Kusum; Gita Negi; Dushyant Singh Gaur; Sanjeev Kishore; Harsh Meena; Anita Sharma; S K Verma
Journal:  Indian J Hematol Blood Transfus       Date:  2008-05-01       Impact factor: 0.900

9.  Sleep and its importance in adolescence and in common adolescent somatic and psychiatric conditions.

Authors:  Serge Brand; Roumen Kirov
Journal:  Int J Gen Med       Date:  2011-06-07

10.  Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study.

Authors:  J Schüz; K Grell; S Kinsey; M S Linet; M P Link; G Mezei; B H Pollock; E Roman; Y Zhang; M L McBride; C Johansen; C Spix; J Hagihara; A M Saito; J Simpson; L L Robison; J D Dockerty; M Feychting; L Kheifets; K Frederiksen
Journal:  Blood Cancer J       Date:  2012-12-21       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.